A randomised controlled feasibility trial of external peripheral neuromodulation in the treatment of intractable localised chronic neuropathic pain

Guy's and St Thomas' NHS Foundation Trust (UK)0 个研究点目标入组 40 人开始时间: 2010年2月18日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Patient age is 18 years or older, either sex
•2. Patient has chronic neuropathic (or predominantly neuropathic) intractable pain
•3. Patient has an area of pain with a typical dermatomal distribution that can be expected to be covered with a single episode of local stimulation
•5. In the opinion of the Investigator and the patient's consultant, all standard medical options have been tried without sufficient improvement in pain control (including opioids, nerve blocks, etc.)
•6. Patient has a Visual Analogue Scale (VAS) pain score of 5 cm (or greater) on a 10 cm line

•1. Patient has a history of substance abuse or substance dependency in the past 6 months prior to baseline data collection
•2. Patient is currently participating in another clinical study
•3. Patient lacks capacity for informed consent to the trial in the view of person taking consent and/or investigators
•4. Pregnancy - if the painful area lies within 50 cm of the gravid uterus
•5. Patient has difficulties in adequate understanding of English for consent, clinical review and self-completion questionnaires
•6. Patient does not permit notification to General Practitioner of enrolment in the study
•7. Patient has previous experience of peripheral neuromodulation. Note that prior transcutaneous electrical nerve stimulation (TENS) experience is permitted.

发起方

Guy's and St Thomas' NHS Foundation Trust (UK)